Welcome to LookChem.com Sign In|Join Free
  • or
Changzhou Sunsanta Chemical Co.,LtdLedipasvir//file1.lookchem.com/cas/reactions/2021/07/06/23926149.png
qq

Communicate with Supplier:

Ms. jessie zhang
Ms. jessie zhang: What can I do for you?

Ledipasvir CAS NO.1256388-51-8

Min.Order Quantity:
1 Gram
Purity:
99%
Port:
Any port in China
Payment Terms:
L/C,D/P,T/T,Other

Add to Inquiry Cart

Product Details

Keywords

  • GS5885
  • high purity Ledipasvir
  • Anti HCV APIs CAS 1256388-51-8 / Ledipasvir

Quick Details

  • ProName: Ledipasvir
  • CasNo: 1256388-51-8
  • Molecular Formula: C49H54F2N8O6
  • Appearance: white powder
  • Application: Ledipasvir (formerly GS-5885) is a dru...
  • DeliveryTime: shipment within 3-5 working days after...
  • PackAge: For small quantity: Bag Commercial qu...
  • Port: Any port in China
  • ProductionCapacity: 10 Kilogram/Month
  • Purity: 99%
  • Storage: Store in a cool, dry place and keep aw...
  • Transportation: air or ocean or rail or parcel post
  • LimitNum: 1 Gram

Superiority

sunsanta
we are one of the leading exporters in china in the fields of active pharma
ingredients including oncology drug, prostaglandin, anti-hiv drug, cardiovascular
drug, diabetes drug, anti-inflammatory drug, urinary system drug, cosmetics peptide
and intermediate, dyestuff & pigment and kinds of package materials.
we specialize in synthesis of novel organic compounds, process development
and manufacturing of pharmaceutical and fine organic chemicals from gram to kilogram quantity.
we supply
1.in very competitive price;
2.quality guaranteed;
3.fast delivery;
4.payment:l/c;d/p;tt;;paypal.
5.on-time shipment and pre-shipment product quality safeguards.

Details

1 specification

ledipasvir (formerly gs-5885) is an experimental drug for the treatment of hepatitis c being developed .[1] it is currently in phase iii clinical trials.[2] it is being studied in combination with other direct-acting antiviral agents that interfere with hcv replication. ledipasvir is an inhibitor of the hepatitis c virus hcv ns5a protein. ledipasvir is being tested in interferon-free regimens with other direct-acting antiviral agents for hepatitis c. data presented at the 20th conference on retroviruses and opportunistic infections in march 2013 showed that a triple regimen of the nucleotide analogue inhibitor sofosbuvir, ledipasvir, and ribavirin produced a 12-week post-treatment sustained virological response (svr12) rate of 100% for both treatment-naive patients and prior non-responders with hcv genotype 1.[3][4] gilead is developing a sofosbuvir + ledipasvir coformulation that is being tested with and without ribavirin.

ledipasivir cas 1256388-51-8 brand: sunsanta
msds: avaiable
mf : c49h54f2n8o6 sample: avaiable

category: anti hcv

min order: 1 grams

quality standard: in-house

place of origin:china
introduction ledipasvir (formerly gs-5885) is a drug for the treatment of hepatitis c. the ledipasvir/sofosbuvir combination is a direct-acting antiviral agent that interferes with hcv replication and can be used to treat patients with genotypes 1a or 1b without peg interferon or ribavirin.
character white to kind of white powder
remark

our products are limited to scientific research and production use only .our products will not be sold to countires and regions under administrative and patent protections.

we can supply other apis as follow:

sofosbuvir cas 1190307-88-0

daclatasvir cas 1009119-64-5

2 quality specification:

contact sunsanta for updated version coa

3 package details:

for small quantity: bag commercial quantity: fiber drum or tin or as per customers required

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)